Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Tesla Q2 deliveries: What to expect from the critical report